Skip to content

The Scheduling of MDMA: A Pharmacist's Perspective

June E. Riedlinger

Journal of Psychoactive Drugs July 1, 1985 DOI: 10.1080/02791072.1985.10472337 (opens in new tab)

Study at a glance

AI-extracted from the abstract
Characteristics Theoretical or philosophical paper Peer reviewed
Topics MDMA
Citations 26
Key points Argues that MDMA's pharmacological properties and therapeutic promise do not justify Schedule I classification, which would impede research and clinical use.

Abstract

(1985). The Scheduling of MDMA: A Pharmacist's Perspective. Journal of Psychoactive Drugs: Vol. 17, No. 3, pp. 167-171.